Skip to main content
Caplight Logo









BugSeq Bioinformatics Inc.

BugSeq Bioinformatics Inc.

Private
VancouverHealthcare & Life Scienceshttps://bugseq.com/

Last Round

Grant

Jul 11, 2024

Total Funding Raised

$1.37M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BugSeq Bioinformatics Inc. is a biotechnology company that provides a fully automated, cloud-based bioinformatics platform for microbiology labs to analyze DNA sequencing data for pathogen identification and antimicrobial resistance prediction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Healthcare Analytics, Precision Medicine, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Keywords

metagenomic sequencingpathogen identificationbioinformatics pipelineinfectious disease diagnosticspathogen surveillancemetagenomicsantimicrobial resistanceAMRclinical genomicsbioinformatics SaaSFASTQ analysistaxonomic classificationbioinformatics APIdigital pathogen detectioncloud bioinformaticsgenomic surveillance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BugSeq Bioinformatics Inc. Comparables

Compare BugSeq Bioinformatics Inc. with similar companies based on industry and business-model similarity.

BugSeq Bioinformatics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Solu Healthcare Oy
88%
Biotia
87%
Edenroc Sciences
79%

BugSeq Bioinformatics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 11, 2024
VC RoundDec 1, 2022
AcceleratorJul 15, 2022
GrantMay 3, 2022
GrantOct 9, 2020

Key People

Founding team and executive leadership

Sam Chorlton

Chief Executive Officer

Executive Team

BugSeq Bioinformatics Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 604% MoM, reaching 1.3K.

  • Jul 11, 2024

    Received grant funding from BARDA and PHEMCE.

BugSeq Bioinformatics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BugSeq Bioinformatics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BugSeq Bioinformatics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range8
Year Founded2020
Last FundingJul 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?